🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer Patients

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery NCT07140172NA55 sites📍 Bethesda📍 Durham📍 Philadelphia University Hospital, Basel, Switzerland · Tests: Axillary lymph node dissection (ALND), Axillary radiotherapy (ART) Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer NCT07563595n/a3 sites📍 Freiburg im Breisgau📍 Paderborn📍 Ravensburg iOMEDICO AG · Tests: Elacestrant, Standard of care (Investigator Choice) AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site📍 Incheon Incheon St.Mary's Hospital · Tests: LLM-assisted chemotherapy side effect management An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites📍 Birmingham📍 New Haven📍 St Louis BeOne Medicines · Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer NCT06039644NA1 site📍 Taipei GenMont Biotech Incorporation · Tests: Probiotic, Placebo CtDNA Based MRD Testing for NAC Monitoring in TNBC NCT06230185n/a14 sites📍 Tucson📍 Aurora📍 Washington D.C. Personalis Inc. Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques NCT04356235n/a1 site📍 Budapest National Institute of Oncology, Hungary · Tests: A: expander-silicone implant exchange and contralateral symmetrization with mastopexy and if needed with volume reducti… Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. NCT05378204NA25 sites📍 Bordeaux📍 Caen📍 Clermont-Ferrand Institut Claudius Regaud · Tests: Main study:, Sub-study: Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy NCT07386444NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Inspiratory muscle training A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: GNC-077 The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer NCT04291378NA8 sites📍 Aalborg📍 Aarhus📍 Copenhagen Danish Breast Cancer Cooperative Group · Tests: Proton versus photon radiation therapy Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer NCT06105684Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Capecitabine Pill Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. NCT06766058NA1 site📍 Singapore National Cancer Centre, Singapore · Tests: Carrier oil, Asian plant extract blend Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors NCT06214598NA2 sites📍 Belgrade📍 Belgrade University of Belgrade · Tests: Supplement, AI diet, Placebo A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. NCT07593820Phase 12 sites📍 Barcelona📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: p95HER2.CAR-TECH2Me CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial NCT05360290NA1 site📍 Shanghai RenJi Hospital · Tests: GILUPI CellCollector® FDG PET-CT in Advanced Breast Cancer NCT07173868n/a1 site📍 Seoul Samsung Medical Center Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer NCT06072807Phase 41 site📍 New York Weill Medical College of Cornell University · Tests: Brain Imaging with 18F-FES 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site📍 Beijing Peking University Third Hospital · Tests: 68Ga-SorB PET/CT A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs NCT06908928Phase 17 sites📍 Duarte📍 La Jolla📍 Aurora Mabwell (Shanghai) Bioscience Co., Ltd. · Tests: bulumtatug fuvedotin, bulumtatug fuvedotin Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. NCT04305834Phase 26 sites📍 Duarte📍 Irvine📍 Long Beach City of Hope Medical Center · Tests: Abemaciclib, Questionnaire Administration X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma NCT04389281Phase 14 sites📍 Washington D.C.📍 Charlotte📍 Durham Immunolight, LLC · Tests: X-PACT Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial) NCT07629206NA3 sites📍 Glendale📍 Portland📍 Germantown IceCure Medical Ltd. · Tests: Cryoablation TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases NCT05866432Phase 21 site📍 Vienna Medical University of Vienna · Tests: Datopotamab deruxtecan Step Count and Treatment Response in Neoadjuvant Breast Cancer NCT07162675n/a2 sites📍 Ankara📍 Ankara Ankara Etlik City Hospital · Tests: Huawei Fit 2 Smartwatch A Study of GC101 TIL in Advanced Breast Cancer (10hospital) NCT05142475EARLY Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Tumor Infiltrating Lymphocytes (TIL) Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients NCT06962163NA1 site📍 Saint-Herblain Institut Cancerologie de l'Ouest · Tests: [68Ga]Ga-PentixaFor PET/CT Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile NCT07455955Phase 21 site📍 Hong Kong Chinese University of Hong Kong · Tests: Standard antiemetic regimen or Olanzapine antiemetic regimen
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy